Informations générales (source: ClinicalTrials.gov)
National Observatory of Bacterial Meningitis in Children and Newborns
Observational
Association Clinique Thérapeutique Infantile du val de Marne (Voir sur ClinicalTrials)
janvier 2001
janvier 2030
29 juin 2024
Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic
treatment recommendations are based on epidemiological and susceptibility data. The
epidemiology of bacterialméningitis has changed in recent years, mainly owing to
widespread use of different conjugate vaccines. The aim of this prospective national
survey is to describe epidemiology of bacteria implicated in bacterial meningitis in
children.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL NOVO | YANGUI | 04/07/2024 11:05:03 | Contacter | ||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| ACTIV - Créteil - France | Corinne Levy, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF)
culture and/or positive CSF antigen testing (Escherichia coli K1, N. meningitidis
serogroups B, A, C, Y and W-135, group B streptococci, Hib, or S. pneumoniae),
and/or positive CSF polymerase chain reaction (PCR), and/or positive blood culture
with CSF pleocytosis (> 10 cells/µL).
- purpura fulminans
- clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF)
culture and/or positive CSF antigen testing (Escherichia coli K1, N. meningitidis
serogroups B, A, C, Y and W-135, group B streptococci, Hib, or S. pneumoniae),
and/or positive CSF polymerase chain reaction (PCR), and/or positive blood culture
with CSF pleocytosis (> 10 cells/µL).
- purpura fulminans
-